The Molecular Genetics Thalassemia Department (MGTD) of the Cyprus Institute of Neurology & Genetics (CING) announces the start of a new project named EDIT-4-IRON: Genome Editing for Iron-Restrictive Therapy of Hereditary and Acquired Hematological Disorders.